There are a lot of times that it isn't feasible, and they are running a large trial with a control group right now. The drug has a reasonable chance of working so people requested compassionate use, so the company figured they might as well track the compassionate use patients to get some data out of them. It's not like they're using this as a basis for getting FDA approval.